Viral response compared to baselinen Week 24 [clinicaltrials_resource:8ac5741aa0ee1a654b961e9c7fb6e0cb]
600mg po bid for 48 weeks
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Viral response compared to baselinen Week 24 [clinicaltrials_resource:8ac5741aa0ee1a654b961e9c7fb6e0cb]
600mg po bid for 48 weeks
Bio2RDF identifier
8ac5741aa0ee1a654b961e9c7fb6e0cb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8ac5741aa0ee1a654b961e9c7fb6e0cb
measure [clinicaltrials_vocabulary:measure]
Viral response compared to baselinen
time frame [clinicaltrials_vocabulary:time-frame]
description
600mg po bid for 48 weeks
identifier
clinicaltrials_resource:8ac5741aa0ee1a654b961e9c7fb6e0cb
title
Viral response compared to baselinen Week 24
@en
type
label
Viral response compared to bas ...... 5741aa0ee1a654b961e9c7fb6e0cb]
@en